Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/07/034854
CTRI/2021/07/034854
Not yet recruiting
未知

To evaluate the skin irritation and sensitisation potential of the 3 Investigational products by repeated application of occlusive patches. - LPR/SKI-002

SKINOVATE LASER COSMETIC SURGERY CENTRE0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
SKINOVATE LASER COSMETIC SURGERY CENTRE
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
SKINOVATE LASER COSMETIC SURGERY CENTRE

Eligibility Criteria

Inclusion Criteria

  • •1\.Healthy male and female volunteers aged 18 to 65 with no active dermatological conditions
  • •2\.Good general and mental health with, in the opinion of the investigator or medically qualified designee with no clinically significant and relevant abnormalities in medical history or upon physical examination
  • •3\.Subjects who have intact skin on the proposed application site; dorsum (scapular region)
  • •4\.Fitzpatrick photo type I to IV skin type
  • •5\.Willingness to participate as evidenced by voluntary written informed consent

Exclusion Criteria

  • •1\.Women who are known to be pregnant or who are intending to become pregnant over the duration of the study
  • •2\.Women who are breast\-feeding
  • •3\.Any history of significant dermatological diseases or conditions or medical conditions known to alter skin appearance or physiologic response (e.g. diabetes,) which could, in the opinion of the Investigator, preclude topical application of the investigational products and/or interfere with the evaluation of the test site reaction.
  • •4\.Presence of open sores, pimples, or cysts at the application site.
  • •5\.Active dermatosis (local or disseminated) that might interfere with the results of the study.
  • •6\.Considered immune compromised.
  • •7\.History of diseases aggravated or triggered by ultraviolet radiation.
  • •8\.Participants with dermatographism.
  • •9\.Currently using any medication which in the opinion of the investigator, may affect the evaluation of the study product, or place the subject at undue risk.
  • •10\.Use of the following topical or systemic medications: immunosuppressants, antihistamines, nonhormonal anti\-inflammatory drugs, and corticosteroids up to 2 weeks before screening visit.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
To Assess the skin irritation potential of Non-Hydroquinone night cream,HA Face Serum,Moisturizer,Hair Strengthening Shampoo,Conditioner,Hair Oil, by repeated application of patches on human ski
CTRI/2023/07/054853Skinovate Laser & Cosmetic Surgery center
Completed
Not Applicable
To Assess the skin irritation potential of face wash, Sunscreen and night cream, by repeated application of patches on human skin.
CTRI/2021/07/034826Mr Amol Khedkar
Not yet recruiting
Not Applicable
To study the irritant and allergic potential of test products in Men and Women.
CTRI/2024/07/070626Dr. Reddys Laboratories Ltd.,
Not yet recruiting
Not Applicable
To study the irritant and allergic potential of a test product in Men and Women.
CTRI/2024/02/062234Dr. Reddys Laboratories Ltd
Completed
Not Applicable
To check is the test product is causing irritation or allergy in men/women after repeated applications of patch.
CTRI/2021/04/033208yka Labs Limited219